In February, after months of transcontinental controversy driven by shareholders, Chile-based CFR and South Africa's Adcock Ingram abandoned their planned $1.2 billion merger. A few months later, Abbott swept in and bought CFR for $3 billion. Now, Adcock shareholder Public Investment Corp. (PIC), which owns 25.5% of the company, is forced to defend its opposition to the CFR deal, thanks to poor quarterly results at Adcock.
DPx, the result of a $2.6 billion merger of Patheon and DSM Pharmaceutical Products, has acquired U.S. contract manufacturer Gallus BioPharmaceuticals.
Patient-recruitment specialist Synexus has expanded its presence in South Africa, buying up another trial site in the country as it touts a growing list of clients.
European Union regulators have set an Oct. 3 deadline for approving or denying Eli Lilly's $5.4 billion bid for the animal health business of Switzerland's Novartis.
Rumors about a potential new phase of the Pfizer/AstraZeneca takeover saga just won't go away, with all the talk giving the U.K. pharma's share price a lift this week.
What's an OTC drugmaker worth in the race to the top of the consumer healthcare space? Potentially more than $5.3 billion, if that drugmaker is Belgium's Omega Pharma.
The story about a potential new takeover offer for AstraZeneca by Pfizer will not die.
The Medtronic-Covidien integration team must be working overtime juggling not only existing products but also those in the deal pipeline. The pair hasn't slowed down at all--between them they have disclosed 5 acquisitions since their own merger announcement in mid-June, three of them this week alone.
Don't send out any save-the-dates for that Allergan special shareholder meeting just yet. Valeant has won a request for an expedited trial over the timing of the meeting, a key step in its $50 billion hostile takeover plans.
Medtronic wants to be known for manufacturing high-quality devices and providing related services as well. To that end, the company today announced the acquisition of privately held Italian company NGC Medical S.p.A.